217 related articles for article (PubMed ID: 18997817)
1. The uPA/uPAR system regulates the bioavailability of PDGF-DD: implications for tumour growth.
Ehnman M; Li H; Fredriksson L; Pietras K; Eriksson U
Oncogene; 2009 Jan; 28(4):534-44. PubMed ID: 18997817
[TBL] [Abstract][Full Text] [Related]
2. PDGF-D is a potent transforming and angiogenic growth factor.
Li H; Fredriksson L; Li X; Eriksson U
Oncogene; 2003 Mar; 22(10):1501-10. PubMed ID: 12629513
[TBL] [Abstract][Full Text] [Related]
3. Structural and functional specificities of PDGF-C and PDGF-D, the novel members of the platelet-derived growth factors family.
Reigstad LJ; Varhaug JE; Lillehaug JR
FEBS J; 2005 Nov; 272(22):5723-41. PubMed ID: 16279938
[TBL] [Abstract][Full Text] [Related]
4. Platelet-derived growth factor D is activated by urokinase plasminogen activator in prostate carcinoma cells.
Ustach CV; Kim HR
Mol Cell Biol; 2005 Jul; 25(14):6279-88. PubMed ID: 15988036
[TBL] [Abstract][Full Text] [Related]
5. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
Hildenbrand R; Schaaf A
Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
[TBL] [Abstract][Full Text] [Related]
6. Regulatory mechanisms for the expression and activity of platelet-derived growth factor receptor.
Funa K; Uramoto H
Acta Biochim Pol; 2003; 50(3):647-58. PubMed ID: 14515146
[TBL] [Abstract][Full Text] [Related]
7. Tissue-type plasminogen activator is not necessary for platelet-derived growth factor-c activation.
Riehle KJ; Johnson MM; Johansson F; Bauer RL; Hayes BJ; Gilbertson DG; Haran AC; Fausto N; Campbell JS
Biochim Biophys Acta; 2014 Feb; 1842(2):318-25. PubMed ID: 24269585
[TBL] [Abstract][Full Text] [Related]
8. Platelet-derived growth factor-C (PDGF-C) activation by serine proteases: implications for breast cancer progression.
Hurst NJ; Najy AJ; Ustach CV; Movilla L; Kim HR
Biochem J; 2012 Feb; 441(3):909-18. PubMed ID: 22035541
[TBL] [Abstract][Full Text] [Related]
9. Urokinase plasminogen activator and urokinase plasminogen activator receptor mediate human stem cell tropism to malignant solid tumors.
Gutova M; Najbauer J; Frank RT; Kendall SE; Gevorgyan A; Metz MZ; Guevorkian M; Edmiston M; Zhao D; Glackin CA; Kim SU; Aboody KS
Stem Cells; 2008 Jun; 26(6):1406-13. PubMed ID: 18403751
[TBL] [Abstract][Full Text] [Related]
10. PDGF-D, a new protease-activated growth factor.
LaRochelle WJ; Jeffers M; McDonald WF; Chillakuru RA; Giese NA; Lokker NA; Sullivan C; Boldog FL; Yang M; Vernet C; Burgess CE; Fernandes E; Deegler LL; Rittman B; Shimkets J; Shimkets RA; Rothberg JM; Lichenstein HS
Nat Cell Biol; 2001 May; 3(5):517-21. PubMed ID: 11331882
[TBL] [Abstract][Full Text] [Related]
11. Urokinase-receptor-mediated phenotypic changes in vascular smooth muscle cells require the involvement of membrane rafts.
Kiyan J; Smith G; Haller H; Dumler I
Biochem J; 2009 Oct; 423(3):343-51. PubMed ID: 19691446
[TBL] [Abstract][Full Text] [Related]
12. The tyrosine phosphatase SHP-2 controls urokinase-dependent signaling and functions in human vascular smooth muscle cells.
Kiyan J; Haller H; Dumler I
Exp Cell Res; 2009 Apr; 315(6):1029-39. PubMed ID: 19133257
[TBL] [Abstract][Full Text] [Related]
13. The PDGF family: four gene products form five dimeric isoforms.
Fredriksson L; Li H; Eriksson U
Cytokine Growth Factor Rev; 2004 Aug; 15(4):197-204. PubMed ID: 15207811
[TBL] [Abstract][Full Text] [Related]
14. Differential proteome expression associated with urokinase plasminogen activator receptor (uPAR) suppression in malignant epithelial cancer.
Saldanha RG; Xu N; Molloy MP; Veal DA; Baker MS
J Proteome Res; 2008 Nov; 7(11):4792-806. PubMed ID: 18808175
[TBL] [Abstract][Full Text] [Related]
15. Tissue plasminogen activator is a potent activator of PDGF-CC.
Fredriksson L; Li H; Fieber C; Li X; Eriksson U
EMBO J; 2004 Oct; 23(19):3793-802. PubMed ID: 15372073
[TBL] [Abstract][Full Text] [Related]
16. PDGF-D activation by macrophage-derived uPA promotes AngII-induced cardiac remodeling in obese mice.
Cheng YW; Zhang ZB; Lan BD; Lin JR; Chen XH; Kong LR; Xu L; Ruan CC; Gao PJ
J Exp Med; 2021 Sep; 218(9):. PubMed ID: 34236404
[TBL] [Abstract][Full Text] [Related]
17. Ab initio molecular orbital calculations on specific interactions between urokinase-type plasminogen activator and its receptor.
Nagase K; Kobayashi H; Yoshikawa E; Kurita N
J Mol Graph Model; 2009 Aug; 28(1):46-53. PubMed ID: 19403319
[TBL] [Abstract][Full Text] [Related]
18. Urokinase-type plasminogen activator is a marker of aggressive phenotype and an independent prognostic factor in mismatch repair-proficient colorectal cancer.
Minoo P; Baker K; Baumhoer D; Terracciano L; Lugli A; Zlobec I
Hum Pathol; 2010 Jan; 41(1):70-8. PubMed ID: 19740518
[TBL] [Abstract][Full Text] [Related]
19. PDGF-C is a new protease-activated ligand for the PDGF alpha-receptor.
Li X; Pontén A; Aase K; Karlsson L; Abramsson A; Uutela M; Bäckström G; Hellström M; Boström H; Li H; Soriano P; Betsholtz C; Heldin CH; Alitalo K; Ostman A; Eriksson U
Nat Cell Biol; 2000 May; 2(5):302-9. PubMed ID: 10806482
[TBL] [Abstract][Full Text] [Related]
20. PDGF-C controls proliferation and is down-regulated by retinoic acid in mouse embryonic palatal mesenchymal cells.
Han J; Xiao Y; Lin J; Li Y
Birth Defects Res B Dev Reprod Toxicol; 2006 Oct; 77(5):438-44. PubMed ID: 17066417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
